Significant business and legal risks threaten emerging and global life science enterprises. Among those are the industry's extensive reliance on external partners for product development and manufacturing (“Contract Development and Manufacturing Organizations” or “CDMOs”).
Process and product complexity have driven an increase in the volume and complexity of data. Most companies have significant (some have most of their) data on paper or spreadsheets which can make their data unreliable.
Read more about how data integrity issues could effect your company.